BIOMAT Database Logo BIOMAT Database Logo

Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2. 2001

L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Department of Bone Biology and Osteoporosis, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

Osteoclast activation is initiated by adhesion to bone, cytoskeletal rearrangement, formation of the sealing zone, and formation of the polarized ruffled membrane. Previous findings suggest that protein-tyrosine kinase 2 (PYK2), a cytoplasmic kinase related to focal adhesion kinase, participates in these events. This study examines the role of PYK2 in adhesion-mediated signaling and osteoclast function, using PYK2 antisense. We produced a recombinant adenovirus containing a 300-base pair reversed 5'-coding region of PYK2 and used full-length PYK2 as a control. Murine osteoclast-like cells or their mononuclear precursors were generated in a co-culture of bone marrow and osteoblasts. Infection with antisense adenovirus significantly reduced the expression of endogenous PYK2 protein relative to uninfected cells or to cells infected with sense PYK2 and caused: 1) a reduction in osteoclast formation in vitro; 2) inhibition of cell spreading and of actin ring formation in osteoclasts plated on glass or bone and of attachment and spreading of osteoclast precursors plated on vitronectin; 3) inhibition of bone resorption in vitro; 4) marked reduction in p130(Cas) tyrosine phosphorylation; and 5) no change in alpha(v)beta(3) integrin expression or c-Src tyrosine phosphorylation. Taken together, these findings support the hypothesis that PYK2 plays a central role in the adhesion-dependent cytoskeletal organization and sealing zone formation required for osteoclastic bone resorption.

UI MeSH Term Description Entries
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D010750 Phosphoproteins Phosphoprotein
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions

Related Publications

L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.
April 1996, Proceedings of the National Academy of Sciences of the United States of America,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Potent and Selective Knockdown of Tyrosine Kinase 2 by Antisense Oligonucleotides.
February 2021, ImmunoHorizons,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Inhibition of protein kinase C by the tyrosine kinase inhibitor erbstatin.
November 1990, Biochemical pharmacology,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Inhibition of phosphorylase kinase, and tyrosine protein kinase activities by quercetin.
August 1985, Biochemical and biophysical research communications,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides.
November 1996, Nucleic acids research,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
In situ inhibition of tyrosine protein kinase by erbstatin.
November 1987, Biochemistry international,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Inhibition of tyrosine protein kinase by synthetic erbstatin analogs.
August 1987, The Journal of antibiotics,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Specific growth inhibition of small-cell lung cancer cells by adenovirus vector expressing antisense c-kit transcripts.
May 1996, Japanese journal of cancer research : Gann,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.
July 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
L T Duong, and I Nakamura, and P T Lakkakorpi, and L Lipfert, and A J Bett, and G A Rodan
Inhibition of bovine mononuclear cell proliferation, interleukin-2 synthesis, protein-tyrosine kinase and leukotriene B4 production by a protein-tyrosine kinase inhibitor, genistein.
September 1993, Veterinary immunology and immunopathology,
Copied contents to your clipboard!